OSLO, Norway, May 11, 2023 /PRNewswire/ -- The annual general meeting of Navamedic ASA (OSE: NAVA) will be held on Thursday, June 1st 2023 at 10:00 (CET) in the Navamedic offices in Henrik Ibsens gate 100, 0255 Oslo. The Notice of the Annual General Meeting is attached. The Notice is posted electronically or by mail to all shareholders and is available on the company's website www.navamedic.com.
On one hand, Takanori Takebe, MD, PhD, would prefer to be remembered for his multiple breakthrough contributions to organoid medicine. However, he may never be forgotten for his work to demonstrate that people can "breathe"...
Halozyme Therapeutics, Inc. ("Halozyme") today announced that Roche received U.S. Food and Drug Administration (FDA) approval for Tecentriq Hybrezatm (atezolizumab and hyaluronidase-tqjs) with Halozyme's ENHANZE® drug delivery technology. Tecentriq...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq Hybrezatm (atezolizumab and hyaluronidase-tqjs), the first and only PD-(L)1 inhibitor for...
Bio-Me AS Announces Appointment of Arne Materna as Co-CEO alongside Dr. Warren Flood
Dr. Arne Materna has been appointed Co-CEO as of July 1st, 2024 to strengthen the company's capitalization and continued commercial growth.Bio-Me reports strong...
Renowned parenting expert, licensed therapist, and author Tammy Gold announces rebranding her services under the new name, Therapeutic Parenting Method with the goal of reducing stress and shame felt by busy parents.
This rebrand aligns with recent...
Journalists and other readers should disregard the news release, MSA Capital Acquires LiveForeverHealth, Appoints Samuel Aziz Boubaous as CEO; Rejuva-Med Division Sold to Franchise Surterra, issued 20-Aug-2024 over PR Newswire.
SOURCE Live Forever...
